Metabolic syndrome in PCOS [polycystic ovary syndrome]: precursors and interventions.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2012
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary) ; Flutamide (Primary) ; Estradiol/drospirenone; Metformin
- Indications Metabolic syndrome; Polycystic ovary syndrome
- Focus Pharmacodynamics; Pharmacogenomic
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Jul 2011 Planned end date changed from 1 Jul 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.